Meeting
2022 ASCO Genitourinary Cancers Symposium
Tumor genomic landscape in younger compared to older patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).
Authors
Nishita Tripathi
Huntsman Cancer Institute, Salt Lake City, UT
Nishita Tripathi , Haoran Li , Yeonjung Jo , Nicolas Sayegh , Clara Tandar , Roberto Nussenzveig , Benjamin Haaland , Jackson Cheney , Divyam Goel , Blake Nordblad , Sumati Gupta , Benjamin L. Maughan , Neeraj Agarwal , Umang Swami
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 373)
DOI
10.1200/JCO.2022.40.6_suppl.373
Abstract #
373
Poster Bd #
H6
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Genomic profiling of nephrectomy and metastatic sites in patients with advanced clear cell renal cell carcinoma (RCC).
First Author: Guillermo de Velasco
Poster
2018 ASCO Annual Meeting
PBRM1 mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.
First Author: Gennady Bratslavsky
Poster
2022 ASCO Annual Meeting
Association between tumor mutational burden (TMB) and mutational profile and its effect on overall survival: A post hoc analysis of patients with TMB-high and TMB-low metastatic cancer treated with immune checkpoint inhibitors (ICI).
First Author: Camila Bragança Xavier
Poster
2019 ASCO Annual Meeting
Comparative genomic profiling from tumor tissue and circulating tumor DNA (ctDNA) in 111 patients (Pts) with metastatic clear cell renal cell carcinoma.
First Author: Ritesh Kotecha